Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 425 of 517 entries
View as:

A Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02426034 Org: User:
Start: 05/15/15 End: 09/03/20 Due: 09/03/21

PD-1 Antibody SHR-1210 in Patients With Relapsed or Refractory Classic Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03155425 Org: User:
Start: 06/09/17 End: 09/30/20 Due: 09/30/21

Food Effect Study of DDO-3055 Tablets in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04197778 Org: User:
Start: 01/06/20 End: 01/18/20 Due: 01/18/21

A Drug-drug Interaction Study of Famitinib Malate With a Proton Pump Inhibitor in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05041920 Org: User:
Start: 09/07/21 End: 10/27/21 Due: 10/27/22

A Study of SHR6390 in Combination With Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03927456 Org: User:
Start: 06/13/19 End: 12/30/22 Due: 12/30/23

A Trial of SP2086 With Hepatic Insufficiency

Phase: N/A Priority: Normal
NCT ID: NCT06035406 Org: User:
Start: 09/30/23 End: 12/31/23 Due: 12/31/24

Effect of a High-fat Meal on the Pharmacokinetics of Hetrombopag and Mass Balance Study in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02409394 Org: User:
Start: 03/31/14 End: 04/30/14 Due: 04/30/15

To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT04957550 Org: User:
Start: 08/30/21 End: 11/13/24 Due: 11/13/25

Phase I Clinical Study of HRS-9815 for PET/CT Imaging in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06062355 Org: User:
Start: 10/31/23 End: 12/31/23 Due: 12/31/24

Safety and Effectiveness of Trappa Ethanolamine Tablets Combined With Ciclosporin in the Treatment of Primary Treatment of Non-severe Aplastic Anemia

Phase: N/A Priority: Normal
NCT ID: NCT05797623 Org: User:
Start: 04/26/23 End: 05/30/25 Due: 05/30/26

Phase III Study ：SHR6390/Placebo Combined With Endocrine Therapy for the Adjuvant Treatment of Hormone Receptor Positive,Human Epidermal Receptor 2 Negative

Phase: N/A Priority: Normal
NCT ID: NCT04842617 Org: User:
Start: 04/30/21 End: 10/31/31 Due: 10/31/32

A Study to Evaluate SHR-1210 in Combination With Capecitabine + Oxaliplatin Sequenced by SHR-1210 + Apatinib as First-line Therapy in Treatment of Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03813784 Org: User:
Start: 03/07/19 End: 06/07/23 Due: 06/07/24

The PK/PD Study of A Single Subcutaneous Injection of SHR-1209 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03634436 Org: User:
Start: 08/30/18 End: 05/28/19 Due: 05/28/20

Study to Evaluate the Mass Balance and Biotransformation of [14C]SHR4640 in Chinese Healthy Adult Male Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT04260373 Org: User:
Start: 03/19/20 End: 04/03/20 Due: 04/03/21

Effect of Fluconazole on Pharmacokinetics of SHR2554 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05661591 Org: User:
Start: 02/28/23 End: 03/31/23 Due: 03/31/24

Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia

Phase: N/A Priority: Normal
NCT ID: NCT01507727 Org: User:
Start: 01/31/12 End: 09/30/12 Due: 09/30/13

A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 in Patients With Advanced Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02738489 Org: User:
Start: 04/13/16 End: 01/08/20 Due: 01/08/21

The PK/PD Study of SHR0532 Tablets in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03645278 Org: User:
Start: 08/24/18 End: 04/30/19 Due: 04/30/20

A Trial of HR17031 Injection With Renal Insufficiency

Phase: N/A Priority: Normal
NCT ID: NCT05292495 Org: User:
Start: 03/31/22 End: 12/30/22 Due: 12/30/23

The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and Omeprazole

Phase: N/A Priority: Normal
NCT ID: NCT04676035 Org: User:
Start: 06/15/20 End: 01/26/22 Due: 01/26/23

Pharmacokinetic Study of Pyrotinib and Docetaxel in Combination With Trastuzumab in Patients With HER2 Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04367090 Org: User:
Start: 05/28/20 End: 05/24/23 Due: 05/24/24

Pharmacokinetic Test of High-fat Diet After Oral Administration of SHR2554 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05592262 Org: User:
Start: 11/15/22 End: 12/14/22 Due: 12/14/23

Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy.

Phase: N/A Priority: Normal
NCT ID: NCT03976882 Org: User:
Start: 11/06/19 End: 02/22/23 Due: 02/22/24

Relative Bioavailability Study of HRG2010 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06976346 Org: User:
Start: 09/10/21 End: 10/07/21 Due: 10/07/22

A Bioequivalence Study of Hetrombopag in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05088655 Org: User:
Start: 06/25/21 End: 11/02/23 Due: 11/02/24